Oskar Hansson
541 – 550 of 618
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
No diagnostic value of plasma clusterin in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer's Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study.
(
- Contribution to journal › Article
-
Mark
Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Diffusion tensor tractography of the posterior cingulate gyrus and corpus callosum does not identify MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
(
- Contribution to journal › Article